Partnering Webinars

  1. Our Experience Creates Reliable Results 6/27/2024

    Hear from inSeption Group clients as they share their experiences, recount their journeys and highlight the exceptional service and support they received.

  2. Ensuring Effective PV Regulatory Intelligence With FSP Partnerships 6/25/2024

    Gain insights into what to look for in an FSP PV partner who can provide solid regulatory expertise and effective safety reporting across pharmaceutical, biotech, and medical device development.

  3. Harnessing The Potential Of Patient-Level Data In Clinical Trials   6/19/2024

    Join our panel of industry leaders as they explore innovative methods and best practices for incorporating fully consented patient data in clinical trials.

  4. Flipping The Drug Development Industry On Its Head 6/18/2024

    The video dives into the obstacles of the traditional outsourcing relationship between CROs and sponsors, and how Altasciences has broken from tradition to offer an alternative model.

  5. Feasibility Strategies For Research-Naïve Sites 6/13/2024

    Feasibility is not just a science, there’s also an art to it, says Nick Palumbo, director, feasibility and study start-up, at Takeda. In this clip he talks about how difficult it is for research sites with limited experience to get on a sponsors’ radar.

  6. Does The Feasibility Process Differ For Rare Diseases? 6/13/2024

    Mimi Ermens, senior director, clinical development operations, global feasibility and start-up support, at CSL Behring answers a question from the audience about whether there is a difference in how you should approach the feasibility process when dealing with rare diseases vs. common diseases.

  7. A Data Scientist's Opinion On Clinical Trial Feasibility 6/13/2024

    How do we define success in the clinical trial feasibility process? Monica Jain, director, R&D data science, Johnson & Johnson Innovative Medicine has a data science background and chimes in with her opinion.

  8. What Data Needs To Be Shared? 6/13/2024

    Nick Palumbo of Takeda explains that with feasibility in clinical trials, it has to be a “two-way street” between the sponsor and sites. He and Mimi Ermens (CSL Behring) talk about the types of questions that need to be asked and the kinds of data that needs to be shared by each stakeholder.

  9. How To Be More Proactive With Feasibility 6/13/2024

    Monica Jain of J&J Innovative Medicine talks about how technologies, real-time monitoring, and performance-based metrics have helped improve the feasibility process and make it more proactive.

  10. Pioneer Clinical Studies' SIP Testimonial 6/13/2024

    CEO and Site Director of Pioneer Clinical Studies Jeff Somerstein tells how Cognizant's Shared Investigator Platform (SIP) has increased his organization's visibility with sponsors.